Immunology Overview - Concepedia

Principles

Definition

Immunology is the branch of science dedicated to the study of the immune system. It investigates the system's structure, function, and responses, focusing on how organisms defend against pathogens, maintain health, and develop disorders such as infections, allergies, and autoimmune conditions, thereby providing the foundation for developing diagnostics, vaccines, and therapies.

Ontological type

Core Mechanisms

Immune-Related Disorders

Clinical Applications

Key developments

Key Figures

Cellular-Humoral Synthesis era

Thomas F. Dougherty [1], associated with Yale University [3] and the University of Minnesota [4], shaped immunology during the Cellular-Humoral Synthesis era. His 1944 paper 'INFLUENCE OF HORMONES ON LYMPHOID TISSUE STRUCTURE AND FUNCTION. THE ROLE OF THE PITUITARY ADRENOTROPHIC HORMONE IN THE REGULATION OF THE LYMPHOCYTES AND OTHER CELLULAR ELEMENTS OF THE BLOOD<sup>1</sup>' [5] highlighted how pituitary-adrenotropic hormones regulate lymphoid architecture and circulating immune cells, a foundational link between endocrine signals and immune organization for this era. Paul Klemperer [2] operated within multiple research settings of the era. His 1948 paper 'THE PATHOGENESIS OF LUPUS ERYTHEMATOSUS AND ALLIED CONDITIONS' [6] advanced understanding of autoimmune disease mechanisms, illustrating how cellular and humoral factors converge in systemic pathology and informing diagnosis and early therapeutic strategies.

Receptor and Presentation Framework era

César Milstein [1] conducted influential work across leading centers such as San Raffaele University of Rome [3] and University of Cambridge [4] during the receptor-centered era of immunology. His key contribution in this era came from the 1975 paper 'Continuous cultures of fused cells secreting antibody of predefined specificity' [7], which established hybridomas and enabled monoclonal antibodies, a crucial framework for defining receptor-specific antigen recognition. J.F. Heremans [2] conducted influential work at Rockefeller University [5] and KU Leuven [6] during the same period. His 1965 paper 'Immunochemical quantitation of antigens by single radial immunodiffusion' [8] introduced quantitative antigen measurement, providing essential tools for assessing immune components and antigen-specific responses that underpinned later receptor-guided recognition and antigen presentation.

Therapeutic Modulation & Integration era

Drew M. Pardoll [1], whose work in this era spanned Rockefeller University [3] and Harvard University [4], helped shape cancer immunotherapy. He contributed to early demonstrations of safety, activity, and immune correlates of anti–PD-1 antibody in cancer [7] and anti–PD-L1 antibody in patients with advanced cancer [8], establishing checkpoint blockade as a therapeutic paradigm, and he highlighted adaptive resistance suggested by the colocalization of inflammatory response with B7-H1 expression in human melanocytic lesions [9]. Suzanne L. Topalian [2], whose career in this era included work across Johns Hopkins University [5] and the University of Washington [6], conducted influential studies. Her contributions include co-leading pivotal clinical studies demonstrating safety, activity, and immune correlates of PD-1/PD-L1 blockade [7][8], and she helped translate mechanistic insights into patient stratification and therapeutic strategies, illuminated by the colocalization findings [9].